Vaxart Inc

NASDAQ: VXRT
$0.60
-$0.01 (-1.4%)
Closing Price on November 21, 2024

VXRT Stock Chart and Intraday Price

VXRT Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 2500 NORTHWINDS PARKWAY, SUITE 100, ALPHARETTA, GE
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 191.76M USD
Shares Outstanding 153,409,000
Vaxart Inc is a trailblazing biotech firm focused on revolutionizing vaccines by making them available in oral tablet form, rather than traditional injections. This innovative approach is being applied to a range of infectious diseases, including norovirus, seasonal influenza, respiratory syncytial virus, coronavirus, and human papillomavirus (HPV), with several vaccines currently undergoing clinical trials. Based in South San Francisco, California, Vaxart's mission is to enhance vaccine accessibility and acceptance worldwide.

VXRT Articles

5 Sizzling Stocks To Buy Now Trading Under $10 With Massive Upside Potential
Here's a look at five stocks, all with serious analyst coverage, currently selling for less than $10 a share.
Lee Jackson
Published:

Nasdaq, Smartsheet, Twilio, Vaxart, Zoom Video and More Friday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Celsius, Nasdaq, SmartSheet, Twilio and Zoom Video.
Chris Lange
Published:

13 Top After-Hours Earnings & News Movers for Thursday, Stocks to Watch for Friday
Earnings season may have peaked, but there are still many companies reporting earnings that are making big moves up or down in their stocks. The S&P 500 has now risen for 5 straight days and the...
Jon C. Ogg
Published:

Why Vaxart's New Flu Vaccine Is So Great
Vaxart shares more than doubled on Thursday after the company announced positive results from the midstage trial of its influenza oral tablet vaccine.
Chris Lange
Published:
Last Updated: